PROXIDRUGS speaker Ivan Đikić visits the Molecular Therapeutics Initiative at the University of California, Berkeley

As part of the ProxiUS program, funded by the Federal Ministry of Research, Technology and Space, PROXIDRUGS speaker Ivan Đikić visited the Molecular Therapeutics Initiative (MTI) at the University of California, Berkeley for scientific exchange and discussion.

The visit highlighted the strong synergy between PROXIDRUGS and MTI. Bringing together complementary expertise and new perspectives, the exchange created valuable opportunities for knowledge transfer, education, and future collaborative activities. Such interactions are essential for advancing innovation at the interface of chemical biology, targeted protein degradation, and therapeutic discovery.

During his visit, Ivan Đikić gave a scientific lecture and engaged in discussions with researchers, students, and postdocs at Berkeley. The exchange once again demonstrated how international collaboration can help connect excellent research environments and inspire new ideas across disciplines.

We thank the MTI for the warm welcome and excellent organization and look forward to further deepening the collaboration between PROXIDRUGS and MTI through future joint activities.